Skip to main navigation Top Menu News Events Careers Products Donors Patients Education Investors About Contact Investor Overview CryoLife, Inc. is a leader in medical device manufacturing and distribution and in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries. It operates throughout the U.S. and internationally. CryoLife manufactures and distributes BioGlue® Surgical Adhesive, an FDA-approved adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. BioGlue is also CE marked in Europe for use in soft tissue repair and has received additional marketing approvals in several other countries throughout the world. CryoLife’s BioFoam® Surgical Matrix is CE marked in Europe for use as an adjunct to hemostasis in cardiovascular surgery and on abdominal parenchymal tissues (liver and spleen) when control of bleeding by ligature or conventional methods is ineffective or impractical. CryoLife distributes PerClot®, a powdered hemostat, in Europe and other select international countries. CryoLife is conducting a pivotal clinical trial in the U.S. for potential FDA approval of the surgical version of PerClot. CryoLife specializes in the... View More Special Meeting Materials 2021 Special Proxy Statement and Notice of Special Meeting Change Volume 52 Week High 52 Week Low Dec 2, 2021 10:24 PM EST Data Provided by Refinitiv. Minimum 15 minutes delayed. Recent News DATE TITLE AND SUMMARY Toggle Summary November 9, 2021 CryoLife to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum Toggle Summary November 4, 2021 CryoLife Reports Third Quarter 2021 Financial Results Toggle Summary October 20, 2021 CryoLife Announces Release Date and Teleconference Call Details for Third Quarter 2021 Financial Results Toggle Summary September 22, 2021 Anthony Semedo Joins CryoLife Board of Directors Toggle Summary August 31, 2021 CryoLife to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference View More Upcoming Events There are currently no events to display. View More Most Recent SEC Filings FILING DATE FORM DESCRIPTION VIEW Dec 01, 2021 4 Statement of changes in beneficial ownership of securities View HTML 0000784199-21-000215.pdf 0000784199-21-000215.rtf 0000784199-21-000215.xls Nov 30, 2021 4 Statement of changes in beneficial ownership of securities View HTML 0000784199-21-000213.pdf 0000784199-21-000213.rtf 0000784199-21-000213.xls Nov 18, 2021 8-K Report of unscheduled material events or corporate event View HTML 0000784199-21-000211.pdf 0000784199-21-000211.rtf 0000784199-21-000211.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Nov 05, 2021 10-Q Quarterly report which provides a continuing view of a company's financial position View HTML 0000784199-21-000207.pdf 0000784199-21-000207.rtf 0000784199-21-000207.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Nov 05, 2021 4 Statement of changes in beneficial ownership of securities View HTML 0000784199-21-000209.pdf 0000784199-21-000209.rtf 0000784199-21-000209.xls View More Print Page RSS Feeds Email Alerts Contact Information Investor Relations Investor Overview Stock Information Financial Information Webcasts and Presentations Analyst Coverage Corporate Governance Email Alerts Information Request Contact Information CryoLife, Inc. - 1655 Roberts Blvd., Kennesaw, GA 30144, U.S.A | 800.438.8285 Footer Privacy Policy Terms of Use Employees Careers Contact Partners